Beijing Anding Hospital

Running trials

• Not yet recruiting

  Context-Guided Personalized iTBS for Depression

  NCT07743398· Source

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Source

• Not yet recruiting

  A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia

  NCT07396870· Phase 2· Source

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  NCT07140913· Phase 3· Source

• Recruiting

  A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

  NCT07230652· Phase 1· Source

• Active, not recruiting

  A Food Effect Study of LY03020 in Healthy Subjects

  NCT07292233· Phase 1· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· Phase 3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  NCT06951711· Phase 3· Source

• Recruiting

  Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder

  NCT06692361· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Source

• Recruiting

  A Bioequivalence Study of PP3M in Patients With Schizophrenia

  NCT07493551· Source

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Source

• Not yet recruiting

  Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing

  NCT06489990· Source

• Recruiting

  The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

  NCT06674694· Phase 1· Source

• Recruiting

  App and Body Fat Scale in the Management of Overweight Patients

  NCT05866107· Source

• Recruiting

  An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

  NCT05908695· Phase 4· Source

• Recruiting

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· Phase 3· Source

• Active, not recruiting

  Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

  NCT05531526· Phase 3· Source

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

  NCT05508789· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia6 recruiting
• Alzheimer disease5 recruiting
• Depression4 recruiting
• Bipolar disorder3 recruiting
• Obesity2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression

  NCT07274917· Source

• Completed

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

  NCT07193901· Phase 2· Source

• Completed

  A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder

  NCT07101120· Phase 2· Source

• Completed

  Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder

  NCT07253207· Phase 3· Source

• Completed

  A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects

  NCT06556966· Phase 1· Source

• Completed

  Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia

  NCT07268430· Source

• Completed

  A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia

  NCT05919823· Phase 3· Source

• Completed

  Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

  NCT05811442· Phase 2· Source

• Completed

  CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

  NCT04860830· Phase 3· Source

Trial sites

• Beijing Anding Hospital4 trials
• Beijing Anding Hospital - Affiliated Capital University of Medical Science6 trials
• Beijing Anding Hospital, Capital Medical University20 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Depression73 works · 8 trials
• Schizophrenia33 works · 11 trials